Alfred K. Cheung
No Rating Available
(Learn About Our Rating System)

Alfred K. Cheung, MD

Languages spoken: Cantonese, English

Alfred K. Cheung is a Professor of Internal Medicine and a faculty member in the Division of Nephrology & Hypertension. He is Board certified in Internal Medicine and Nephrology. His research interests are clinical aspects of chronic kidney disease, hemodialysis and hypertension. He currently serves as the Vice Chair for Research in the Department of Internal Medicine.

Specialties

Board Certification

American Board of Internal Medicine (Sub: Nephrology)
American Board of Internal Medicine (Internal Medicine)
National Board of Medical Examiners

Alfred K. Cheung is a Professor of Internal Medicine and a faculty member in the Division of Nephrology & Hypertension. He is Board certified in Internal Medicine and Nephrology. His research interests are clinical aspects of chronic kidney disease, hemodialysis and hypertension. He currently serves as the Vice Chair for Research in the Department of Internal Medicine.

Board Certification and Academic Information

Academic Departments Internal Medicine -Professor
Academic Divisions Nephrology & Hypertension
Board Certification
American Board of Internal Medicine (Sub: Nephrology)
American Board of Internal Medicine (Internal Medicine)
National Board of Medical Examiners

Education history

Undergraduate State University of New York B.A.
Professional Medical Medicine - Albany Medical College M.D.
Internship Loma Linda University Intern
Residency Internal Medicine - Loma Linda University Resident
Fellowship Clinical Nephrology - University of California - San Diego Fellow
Fellowship Research Nephrology - University of California - San Diego Fellow

Selected Publications

Journal Article

  1. Chang TI, Shilane D, Brunelli SM, Cheung AK, Chertow GM, Winkelmayer WC (2011). Angiotensin-converting enzyme inhibitors and cardiovascular outcomes in patients on maintenance hemodialysis. Am Heart J, 162, 324-330.
  2. Thekkedath UR, Chirananthavat T, Leypoldt JK, Cheung AK, Mohammad SF (2006). Elevated fibrinogen fragment levels in uremic plasma inhibit platelet function and expression of glycoprotein IIb-IIIa. Am J Hematol, 81(12), 915-26.
  3. Cheung AK, Wu LL, Kablitz C, Leypoldt J (1993). Atherogenic lipids and lipoproteins in hemodialysis patients. American journal of kidney diseases, 22(2), 271-6.
  4. Steuer RR, Leypoldt JK, Cheung AK, Senekjian HO, Conis J (1996). Reducing symptoms during hemodialysis by continuously monitoring the hematocrit. American journal of kidney diseases, 27(4), 525-32.
  5. Leypoldt JK, Cheung AK, Deeter R (1998). Effect of hemodialyzer reuse: dissociation between clearances of small and large solutes. American journal of kidney diseases, 32(2), 295-301.
  6. Munger MA, Ateshkadi A, Cheung AK, Flaharty KK, Stoddard GJ, Marshall E (2000). Cardiopulmonary events during hemodialysis: effects of dialysis membranes and dialysate buffers. American journal of kidney diseases, 36(1), 130-9.
  7. Leypoldt JK, Cheung A (2001). Increases in mass transfer-area coefficients and urea Kt/V with increasing dialysate flow rate are greater for high-flux dialyzers. American journal of kidney diseases, 38(3), 575-9.
  8. Beddhu S, Kaysen GA, Yan G, Sarnak M, Agodoa L, Ornt D, Cheung A (2002). Association of serum albumin and atherosclerosis in chronic hemodialysis patients. American journal of kidney diseases, 40(4), 721-7.
  9. Goldfarb-Rumyantzev AS, Cheung AK, Leypoldt J (2002). Computer simulation of small-solute and middle-molecule removal during short daily and long thrice-weekly hemodialysis. American journal of kidney diseases, 40(6), 1211-8.
  10. Beddhu S, Kimmel PL, Ramkumar N, Cheung A (2005). Associations of metabolic syndrome with inflammation in CKD: results From the Third National Health and Nutrition Examination Survey (NHANES III). American journal of kidney diseases, 46(4), 577-86.
  11. Delmez JA, Yan G, Bailey J, Beck GJ, Beddhu S, Cheung AK, Kaysen GA, Levey AS, Sarnak MJ, Schwab S (2006). Cerebrovascular disease in maintenance hemodialysis patients: results of the HEMO Study. American journal of kidney diseases, 47(1), 131-8.
  12. Ramkumar N, Murtaugh MA, Cheung AK, Beddhu (2007). Lack of synergistic effects of metabolic syndrome and plasma fibrinogen on coronary events and mortality in moderate CKD. American journal of kidney diseases, 49(3), 356-64.
  13. Goldfarb-Rumyantzev AS, Habib AN, Baird BC, Barenbaum LL, Cheung A (2007). The association of lipid-modifying medications with mortality in patients on long-term peritoneal dialysis. American journal of kidney diseases, 50(5), 791-802.
  14. Wald R, Sarnak MJ, Tighiouart H, Cheung AK, Levey AS, Eknoyan G, Miskulin D (2008). Disordered mineral metabolism in hemodialysis patients: an analysis of cumulative effects in the Hemodialysis (HEMO) Study. American journal of kidney diseases, 52(3), 531-40.
  15. Ing TS, Cheung AK, Golper TA, Lang GR, Lazarus JM, Letteri JM, Levin NW, Lundin AP, Molony DA, Mujais SK, Port FK, Ward R (1997). National Kidney Foundation report on dialyzer reuse. American journal of kidney diseases, 30, 859-871.
  16. Leypoldt JK, Cheung AK, Carroll CE, Stannard DC, Pereira BJG, Agodoa LY, Port F (1999). Effect of dialysis membranes and middle molecule removal on chronic hemodialysis patient survival. American journal of kidney diseases, 33, 349-355.
  17. Kendrick J, Cheung AK, Kaufman JS, Greene T, Roberts WL, Smits G, Chonchol M, HOST Study Investigator (2012). Associations of plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D concentrations with death and progression to maintenance dialysis in patients with advanced kidney disease. American journal of kidney diseases, Epub ahead, of print.
  18. Tangri N, Shastri S, Tighiouart H, Beck GJ, Cheung AK, Eknoyan G, Sarnak M (2011). Beta-blockers for prevention of sudden cardiac death in patients on hemodialysis: A propensity score analysis of the HEMO Study. American journal of kidney diseases, 58, 939-945.
  19. Kendrick J, Cheung AK, Kaufman JS, Greene T, Roberts WL, Smits G, Chonchol MB, and the HOST Investigator (2012). : A biodegradable perivascular wrap for controlled, local and directed drug delivery. American journal of kidney diseases,
  20. Dember LM, Imrey PB, Beck GJ, Cheung AK, Himmelfarb J, Huber TS, Kusek JW, Roy-Chaudhury P, Vazquez MA, Alpers CE, Robbin ML, Vita JA, Greene T, Gassman JJ, Feldman HI (2014). Hemodialysis Fistula Maturation Study Group: Objectives and design of the Hemodialysis Fistula Maturation Study. (PMID: 23992885). American journal of kidney diseases, (63), 104-112.
  21. Rocco MV, Yan G, Heyka RJ, Benz R, Cheung A (2001). Risk factors for hypertension in chronic hemodialysis patients: baseline data from the HEMO study. American journal of nephrology, 21(4), 280-8.
  22. Goldfarb-Rumyantzev AS, Cheung AK, Habib AN, Wang BJ, Lin SJ, Baird BC, Naiman N, Cannon-Albright (2006). A population-based assessment of the familial component of chronic kidney disease mortality. American journal of nephrology, 26(2), 142-8.
  23. Chonchol M, Goldenberg I, Moss AJ, McNitt S, Cheung A (2007). Risk factors for sudden cardiac death in patients with chronic renal insufficiency and left ventricular dysfunction. American journal of nephrology, 27(1), 7-14.
  24. Naiman N, Cheung AK, Goldfarb-Rumyantzev A (2009). Familiality of cardiovascular mortality in end-stage renal disease patients. American journal of nephrology, 29(3), 237-43.
  25. 141. Montford JR, Chonchol M, Cheung AK, Kaufman JS, Greene T, Roberts WL, Smits G, Kendrick J (2013). Low body mass index and dyslipidemia in dialysis patients linked to elevated plasma fibroblast growth factor 23. American journal of nephrology, (37:183-190),
  26. Jovanovich AJ, Chonchol MB, Sobhi A, Kendrick JB, Cheung AK, Kaufman JS, Smits G, Jablonski KL and the HOST Investigators (2015). Mineral metabolites, angiotensin II inhibition, and outcomes in advanced chronic kidney disease. in press. American journal of nephrology,
  27. Kozek-Langenecker SA, Mohammad SF, Masaki T, Green W, Kamerath C, Cheung A (2000). The effects of aprotonin on platelets in vitro using whole blood flow cytometry. Anesthesia and analgesia, 90(1), 12-6.
  28. Kozek-Langenecker SA, Mohammad SF, Masaki T, Kamerath C, Cheung A (2000). The effects of heparin, protamine, and heparinase 1 on platelets in vitro using whole blood flow cytometry. Anesthesia and analgesia, 90(4), 808-12.
  29. Steuer RR, Germain MJ, Leypoldt JK, Cheung A (1998). Enhanced fluid removal guided by blood volume monitoring during chronic hemodialysis. Artificial organs, 22(8), 627-32.
  30. Zhu W, Masaki T, Cheung AK, Kern S (2006). Cellular pharmacokinetics and pharmacodynamics of dipyridamole in vascular smooth muscle cells. Biochemical pharmacology, 72(8), 956-64.
  31. Terry CM, Carlson ML, He Y, Ulu A, Morisseau C, Blumenthal DK, Hammock BD, Cheung AK (2014). Aberrant soluble epoxide hydrolase and oxylipin levels in a porcine arteriovenous graft stenosis model, (PMID: 25196102). Journal of vascular research, (51), 269-282.
  32. Leypoldt JK, Cheung AK, Steuer RR, Harris DH, Conis J (1995). Determination of circulating blood volume by continuously monitoring hematocrit during hemodialysis. Journal of the American Society of Nephrology, 6(2), 214-9.
  33. Cheung AK, Faezi-Jenkin B, Leypoldt J (1994). Effect of thrombosis on complement activation and neutrophil degranulation during in vitro hemodialysis. Journal of the American Society of Nephrology, 5(1), 110-5.
  34. Cheung AK, DeVault GA Jr, Gregory M (1993). A prospective study on treatment of hypercholesterolemia with lovastatin in renal transplant patients receiving cyclosporine. Journal of the American Society of Nephrology, 3(12), 1884-91.
  35. Bergstrom J, Lysaght M, Cheung A (2002). The career of Lee W. Henderson. Journal of the American Society of Nephrology, 13 Suppl 1, S1-2.
  36. Cheung AK, Yan G, Greene T, Daugirdas JT, Dwyer JT, Levin NW, Ornt DB, Schulman G, Eknoyan (2002). Seasonal variations in clinical and laboratory variables among chronic hemodialysis patients. Journal of the American Society of Nephrology, 13(9), 2345-52.
  37. Beddhu S, Samore MH, Roberts MS, Stoddard GJ, Pappas LM, Cheung A (2003). Creatinine production, nutrition, and glomerular filtration rate estimation. Journal of the American Society of Nephrology, 14(4), 1000-5.
  38. Beddhu S, Samore MH, Roberts MS, Stoddard GJ, Ramkumar N, Pappas LM, Cheung A (2003). Impact of timing of initiation of dialysis on mortality. Journal of the American Society of Nephrology, 14(9), 2305-12.
  39. Cheung AK, Levin NW, Greene T, Agodoa L, Bailey J, Beck G, Clark W, Levey AS, Leypoldt JK, Ornt DB, Rocco MV, Schulman G, Schwab S, Teehan B, Eknoyan (2003). Effects of high-flux hemodialysis on clinical outcomes: results of the HEMO study. Journal of the American Society of Nephrology, 14(12), 3251-63.
  40. Cheung AK, Rocco MV, Yan G, Leypoldt JK, Levin NW, Greene T, Agodoa L, Bailey J, Beck GJ, Clark W, Levey AS, Ornt DB, Schulman G, Schwab S, Teehan B, Eknoyan (2006). Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO study. Journal of the American Society of Nephrology, 17(2), 546-55.
  41. Chang, TI, Paik, J, Greene T, Desai M, Bech F, Cheung AK, Chertow G (2011). Intradialytic hypotension and vascular access thrombosis. Journal of the American Society of Nephrology, 22, 1526-1533.
  42. Cheung AK, Agodoa LY, Clark W, Daugirdas, JT, Depner TA, Gotch FA, Greene T, Levin NW, Leypoldt JK, and the Hemodialysis (HEMO) Stud (1999). Effects of hemodialyzer reuse on clearances of urea and ß2-microglobulin. Journal of the American Society of Nephrology, 10, 117-127.
  43. Kendrick J, Cheung AK, Kaufman JS, Greene T, Roberts WL, Smits G, Chonchol M, HOST Investigator (2011). FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis. Journal of the American Society of Nephrology, 22, 1913-1922.
  44. Yan G, Norris KC, Xin W, Ma JZ, Yu AJ, Greene T, Yu W, Cheung AK (2013). Facility size, race and ethnicity, and mortality for in-center hemodialysis. (PMID: 23970120). Journal of the American Society of Nephrology, (24), 2062-2070.
  45. Chonchol M, Greene T, Zhang Y, Hoofnagle AN, Cheung A (2015). Low vitamin D and high fibroblast growth factor 23 serum levels associate with infectious and cardiac deaths in the HEMO Study. (Epub ahead of print ). Journal of the American Society of Nephrology, (PMID: 2597143.
  46. Mehrotra R, Soohoo M, Rivara M, Himmelfarb J, Cheung AK, Arah OA, Nissenson A, Ravel V, Streja E, Kuttykrishnan S, Katz R, Molnar MZ, Kalantar-Zadeh (2015). Racial and ethnic disparities in utilization of and outcomes with home dialysis in the United States. Journal of the American Society of Nephrology, (27), 2123-2134.
  47. Leypoldt JK, Gilson JF, Blindauer KM, Cheung A (1992). Macromolecule adsorption to hemodialysis membranes depends on molecular size. Blood purification, 10(1), 53-60.
  48. Masaki T, Kamerath CD, Kim SJ, Leypoldt JK, Mohammad SF, Cheung A (2004). In vitro pharmacological inhibition of human vascular smooth muscle cell proliferation for the prevention of hemodialysis vascular access stenosis. Blood purification, 22(3), 307-12.
  49. Zhang J, Gu C, Lawrence DA, Cheung AK, Huang (2014). A plasminogen activator inhibitor type 1 mutant retards diabetic nephropathy in db/db mice by protecting podocytes. (PMID: 24443353). Experimental physiology, (99), 802-815.
  50. Steuer RR, Leypoldt JK, Cheung AK, Harris DH, Conis J (1994). Hematocrit as an indicator of blood volume and a predictor of intradialytic morbid events. ASAIO journal (American Society for Artificial Internal Organs, 40(3), M691-6.
  51. Leypoldt JK, Cheung AK, Deeter R (1997). Single compartment models for evaluating beta 2-microglobulin clearance during hemodialysis. ASAIO journal (American Society for Artificial Internal Organs, 43(6), 904-9.
  52. Leypoldt JK, Cheung AK, Chirananthavat T, Gilson JF, Kamerath CD, Deeter R (2003). Hollow fiber shape alters solute clearances in high flux hemodialyzers. ASAIO journal (American Society for Artificial Internal Organs, 49(1), 81-7.
  53. Depner TA, Greene T, Daugirdas JT, Cheung AK, Gotch FA, Leypoldt J (2004). Dialyzer performance in the HEMO Study: in vivo K0A and true blood flow determined from a model of cross-dialyzer urea extraction. ASAIO journal (American Society for Artificial Internal Organs, 50(1), 85-93.
  54. Beddhu S, Baird B, Ma X, Cheung AK, Greene (2010). Serum alkaline phosphatase and mortality in hemodialysis patients. Clinical nephrology, 74(2), 91-6.
  55. Sharma S, Joseph J, Chonchol M, Kaufman JS, Cheung AK, Rafeq Z, Smits G, Kendrick (2013). Higher fibroblast growth factor-23 concentrations associate with left ventricular systolic dysfunction in dialysis patients. (PMID: 23849306). Clinical nephrology, (80), 313-321.
  56. Jovanovich AJ, Chonchol M, Brady CB, Kaufman JD, Kendrick J, Cheung AK, Jablonski K (2014). 25-Vitamin D, 1,25-vitamin D, parathyroid hormone, fibroblast growth factor-23 and cognitive function in men with advanced CKD: A veteran population, (PMID: 25208315). Clinical nephrology, (82), 296-303.
  57. Zhou G, Cheung AK, Liu X, Huang (2014). Valsartan slows the progression of diabetic nephropathy in db/db mice via reduction in podocyte injury and renal oxidative stress and inflammation.(PMID: 24195695). Clinical science (London, England, (126), 707-720.
  58. Leypoldt JK, Cheung A (2002). Optimal use of hemodialyzers. Contributions to nephrology, (137), 129-37.
  59. Bress AP, King JB, Kreider KE, Beddhu S, Simmons DL, Cheung AK, Zhang Y, Doumas M, Nord J, Sweeney ME, Taylor AA, Herring C, Kostis WJ, Powell J, Rastogi A, Roumie CL, Wiggers A, Williams JS, Yunis R, Zias A, Evans GW, Greene T, Rocco MV, Cushman WC, Reboussin DM, Feinglos MN, Papademetriou V, SPRINT Research Group (2017). Effect of Intensive Versus Standard Blood Pressure Treatment According to Baseline Prediabetes Status: A Post Hoc Analysis of a Randomized Trial. Diabetes care, 40(10), 1401-1408.
  60. Preston JS, Tasdizen T, Terry CM, Cheung AK, Kirby R (2009). Using the stochastic collocation method for the uncertainty quantification of drug concentration due to depot shape variability. IEEE transactions on bio-medical engineering, 56(3), 609-20.
  61. 68. Zebrack JS, Anderson JL, Beddhu S, Horne BD, Bair TL, Cheung A, Muhlestein JB for the Intermountain Heart Collaborative Study Grou (2003). Do Associations with C-reactive protein and extent of coronary artery disease account for the increased cardiovascular risk of renal insufficiency?. Journal of the American College of Cardiology, 42, 57-63.
  62. Lee RM, Masaki T, Yang HS, Liu J, Chen J, Li L, Blumenthal DK, Cheung A (2006). Different signaling responses to anti-proliferative agents in human aortic and venous smooth muscle cells. Journal of cellular biochemistry, 99(3), 835-44.
  63. Li L, Blumenthal DK, Masaki T, Terry CM, Cheung A (2006). Differential effects of imatinib on PDGF-induced proliferation and PDGF receptor signaling in human arterial and venous smooth muscle cells. Journal of cellular biochemistry, 99(6), 1553-63.
  64. Li L, Blumenthal DK, Terry CM, He Y, Carlson ML, Cheung A (2011). PDGF-induced proliferation in human arterial and venous smooth muscle cells: molecular basis for differential effects of PDGF isoforms. Journal of cellular biochemistry, 112, 289-298.
  65. Brinton, MR, Tagge CA, Stewart RJ, Cheung AK, Shiu YT, Christensen D (2012). Thermal sensitivity of endothelial cells on synthetic vascular graft material . International journal of hyperthermia, 28, 163-174.
  66. Kim SJ, Masaki T, Leypoldt JK, Kamerath CD, Mohammad SF, Cheung A (2004). Arterial and venous smooth-muscle cells differ in their responses to antiproliferative drugs. The Journal of laboratory and clinical medicine, 144(3), 156-62.
  67. Chang TI, Friedman GD, Cheung AK, Greene T, Desai M, Chertow G (2011). Systolic blood pressure and mortality in prevalent haemodialysis patients in the HEMO study. Journal of human hypertension, 25(2), 98-105.
  68. Chang, TI, Flythe JE, Brunelli SM, Muntner P, Greene T, Cheung AK, Chertow G (2014). Visit-to-visit systolic blood pressure variability and outcomes in hemodialysis. (PMID: 23803593). Journal of human hypertension, 28, 18-24.
  69. Moser L, Callahan KS, Cheung AK, Stoddard GJ, Munger M (1997). ACE inhibitor effects on platelet function in stages I-II hypertension. Journal of cardiovascular pharmacology, 30(4), 461-7.
  70. Cheung AK, Parker CJ, Hohnholt (1994). Soluble complement receptor type 1 inhibits complement activation induced by hemodialysis membranes in vitro. Kidney international, 46(6), 1680-7.
  71. Cheung AK, Parker CJ, Hohnholt (1993). Beta2 integrins are required for neutrophil degranulation induced by hemodialysis membranes. Kidney international, 43(3), 649-60.
  72. Leypoldt JK, Charney DI, Cheung AK, Naprestek CL, Akin BH, Shockley T (1995). Ultrafiltration and solute kinetics using low sodium peritoneal dialysate. Kidney international, 48(6), 1959-66.
  73. Cheung AK, Parker CJ, Ren K, Iverius P (1996). Increased lipase inhibition in uremia: identification of pre-beta-HDL as a major inhibitor in normal and uremic plasma. Kidney international, 49(5), 1360-71.
  74. Leypoldt JK, Cheung AK, Agodoa LY, Daugirdas JT, Greene T, Keshaviah P (1997). Hemodialyzer mass transfer-area coefficients for urea increase at high dialysate flow rates. The Hemodialysis (HEMO) Study. Kidney international, 51(6), 2013-7.
  75. Kozek-Langenecker SA, Masaki T, Mohammad H, Green W, Mohammad SF, Cheung A (1999). Fibrinogen fragments and platelet dysfunction in uremia. Kidney international, 56(1), 299-305.
  76. Yarar D, Cheung AK, Sakiewicz P, Lindsay RM, Paganini EP, Steuer RR, Leypoldt J (1999). Ultrafiltration method for measuring vascular access flow rates during hemodialysis. Kidney international, 56(3), 1129-35.
  77. Leypoldt JK, Cheung AK, Deeter R (1999). Rebound kinetics of beta2-microglobulin after hemodialysis. Kidney international, 56(4), 1571-7.
  78. Luo Q, Cheung AK, Kamerath CD, Reimer LG, Leypoldt J (2000). Increased protein loss during peritonitis associated with peritoneal dialysis is neutrophil dependent. Kidney international, 57(4), 1736-42.
  79. Cheung AK, Sarnak MJ, Yan G, Dwyer JT, Heyka RJ, Rocco MV, Teehan BP, Levey A (2000). Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney international, 58(1), 353-62.
  80. Peng H, Cheung AK, Reimer LG, Kamerath CD, Leypoldt J (2001). Effect of indomethacin on peritoneal protein loss in a rabbit model of peritonitis. Kidney international, 59(1), 44-51.
  81. Leypoldt JK, Cheung AK, Delmez JA, Gassman JJ, Levin NW, Lewis JA, Lewis JL, Rocco M (2002). Relationship between volume status and blood pressure during chronic hemodialysis. Kidney international, 61(1), 266-75.
  82. Beddhu S, Allen-Brady K, Cheung AK, Horne BD, Bair T, Muhlestein JB, Anderson J (2002). Impact of renal failure on the risk of myocardial infarction and death. Kidney international, 62(5), 1776-83.
  83. Cheung AK, Sarnak MJ, Yan G, Berkoben M, Heyka R, Kaufman A, Lewis J, Rocco M, Toto R, Windus D, Ornt D, Levey A (2004). Cardiac diseases in maintenance hemodialysis patients: results of the HEMO Study. Kidney international, 65(6), 2380-9.
  84. Leypoldt JK, Cheung AK, Deeter RB, Goldfarb-Rumyantzev A, Greene T, Depner TA, Kusek (2004). Kinetics of urea and beta-microglobulin during and after short hemodialysis treatments. Kidney international, 66(4), 1669-76.
  85. Masaki T, Rathi R, Zentner G, Leypoldt JK, Mohammad SF, Burns GL, Li L, Zhuplatov S, Chirananthavat T, Kim SJ, Kern S, Holman J, Kim SW, Cheung A (2004). Inhibition of neointimal hyperplasia in vascular grafts by sustained perivascular delivery of paclitaxel. Kidney international, 66(5), 2061-9.
  86. Kuji T, Masaki T, Goteti K, Li L, Zhuplatov S, Terry CM, Zhu W, Leypoldt JK, Rathi R, Blumenthal DK, Kern SE, Cheung A (2006). Efficacy of local dipyridamole therapy in a porcine model of arteriovenous graft stenosis. Kidney international, 69(12), 2179-85.
  87. Huang CX, Tighiouart H, Beddhu S, Cheung AK, Dwyer JT, Eknoyan G, Beck GJ, Levey AS, Sarnak M (2010). Both low muscle mass and low fat are associated with higher all-cause mortality in hemodialysis patients. Kidney international, 77(7), 624-9.
  88. Damera S, Raphael KL, Baird BC, Cheung AK, Greene T, Beddhu (2011). Serum alkaline phosphatase levels associate with elevated serum C-reactive protein in chronic kidney disease. Kidney international, 79(2), 228-33.
  89. Kim S-J, Masaki T, Rowley R, Leypoldt JK, Mohammad SF, Cheung A (2005). Different responses by cultured aortic and venous smooth muscle cells to radiation. Kidney international, 68, 371-377.
  90. Leypoldt JK, Cheung A (1996). Removal of high-molecular-weight solutes during high-efficiency and high-flux haemodialysis. Nephrology, dialysis, transplantation, 11(2), 329-35.
  91. Masaki T, Gilson J, Leypoldt JK, Cheung A (1999). Effect of permeability on indices of haemodialysis membrane biocompatibility. Nephrology, dialysis, transplantation, 14(5), 1176-81.
  92. Goldfarb-Rumyantzev A, Hurdle JF, Scandling J, Wang Z, Baird B, Barenbaum L, Cheung A (2005). Duration of end-stage renal disease and kidney transplant outcome. Nephrology, dialysis, transplantation, 20(1), 167-75.
  93. Rocco MV, Cheung AK, Greene T, Eknoyan (2005). The HEMO Study: applicability and generalizability. Nephrology, dialysis, transplantation, 20(2), 278-84.
  94. Goldfarb-Rumyantzev AS, Baird BC, Leypoldt JK, Cheung A (2005). The association between BP and mortality in patients on chronic peritoneal dialysis. Nephrology, dialysis, transplantation, 20(8), 1693-701.
  95. Goldfarb-Rumyantzev AS, Leypoldt JK, Nelson N, Kutner NG, Cheung A (2006). A crossover study of short daily haemodialysis. Nephrology, dialysis, transplantation, 21(1), 166-75.
  96. Goldfarb-Rumyantzev AS, Hurdle JF, Baird BC, Stoddard G, Wang Z, Scandling JD, Barenbaum LL, Cheung A (2006). The role of pre-emptive re-transplant in graft and recipient outcome. Nephrology, dialysis, transplantation, 21(5), 1355-64.
  97. Habib AN, Baird BC, Leypoldt JK, Cheung AK, Goldfarb-Rumyantzev A (2006). The association of lipid levels with mortality in patients on chronic peritoneal dialysis. Nephrology, dialysis, transplantation, 21(10), 2881-92.
  98. Terry CM, Blumenthal DK, Sikharam S, Li L, Kuji T, Kern SE, Cheung A (2006). Evaluation of histological techniques for quantifying haemodialysis arteriovenous (AV) graft hyperplasia. Nephrology, dialysis, transplantation, 21(11), 3172-9.
  99. Kuji T, Masaki T, Li L, Cheung A (2007). Expression of C-reactive protein in myointimal hyperplasia in a porcine arteriovenous graft model. Nephrology, dialysis, transplantation, 22(9), 2469-75.
  100. Li L, Terry CM, Blumenthal DK, Kuji T, Masaki T, Kwan BC, Zhuplatov I, Leypoldt JK, Cheung A (2007). Cellular and morphological changes during neointimal hyperplasia development in a porcine arteriovenous graft model. Nephrology, dialysis, transplantation, 22(11), 3139-46.
  101. Kopple JD, Cheung AK, Christiansen JS, Djurhuus CB, Nahas ME, Feldt-Rasmussen B, Mitch WE, Wanner C, Göthberg M, T. Ikizler T (2011). OPPORTUNITYTM: A large-scale randomized clinical trial of growth hormone in hemodialysis patients. Nephrology, dialysis, transplantation, 26, 4095-4103.
  102. Raphael KL, Zhang Y, Wei G, Greene T, Cheung AK, Beddhu S, El Nahas (2013). Serum bicarbonate and mortality in adults in NHANES III. (PMID: 23348878). Nephrology, dialysis, transplantation, (28), 1207-12.
  103. Kuttykrishnan S, Kalantar-Zadeh K, Arah OA, Cheung AK, Brunelli S, Heagerty PJ, Katz R, Molnar MZ, Nissenson A, Ravel V, Streja E, Himmelfarb J, Mehrotra (2015). Predictors of treatment with dialysis modalities in observational studies for comparative effectiveness research. (PMID: 25883196). Nephrology, dialysis, transplantation, 1208-1217.
  104. Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, Allon M, Bailey J, Delmez JA, Depner TA, Dwyer JT, Levey AS, Levin NW, Milford E, Ornt DB, Rocco MV, Schulman G, Schwab SJ, Teehan BP, Toto (2002). Effect of dialysis dose and membrane flux in maintenance hemodialysis. The New England journal of medicine, 347(25), 2010-9.
  105. Wright JT, Williamson JD, Whelton PK, Snyder JK, Sink KM, Rocco MV, Reboussin DM, Mahboob Rahman M, Oparil S, Lewis CE, Kimmel PL, Johnson KC, Goff DC, Fine LJ, Cutler JA, Cushman WC, Cheung AK, Ambrosius WT, for the SPRINT Study Research Group (2015). A randomized trial of intensive versus standard blood pressure control. The New England journal of medicine,
  106. Munger MA, Gardner SF, Ateshkadi A, Rabetoy GM, Barri YM, Stoddard GJ, Cheung A (2008). Misoprostol effects on diclofenac-induced cardiorenal changes in salt-sensitive patients with hypertension: the MEDIC Study. Pharmacotherapy, 28(7), 834-42.
  107. Goteti K, Masaki T, Kuji T, Leypoldt JK, Cheung AK, Kern S (2006). Perivascular tissue pharmacokinetics of dipyridamole. Pharmaceutical research, 23(4), 718-28.
  108. Cheung AK, Leypoldt J (1997). The hemodialysis membranes: a historical perspective, current state and future prospect. Seminars in nephrology, 17(3), 196-213.
  109. Chelamcharla M, Leypoldt JK, Cheung A (2005). Dialyzer membranes as determinants of the adequacy of dialysis. Seminars in nephrology, 25(2), 81-9.
  110. Terry CM, Kim SE, Li L, Goodrich KC, Hadley JR, Blumenthal DK, Parker DL, Cheung A (2009). Longitudinal assessment of hyperplasia using magnetic resonance imaging without contrast in a porcine arteriovenous graft model. Academic radiology, 16(1), 96-107.
  111. Morton KA, Pisani DE, Whiting JH Jr, Cheung AK, Arias JM, Valdivia (1997). Determination of glomerular filtration rate using technetium-99m-DTPA with differing degrees of renal function. Journal of nuclear medicine technology, 25(2), 110-4.
  112. Owen SC, Li H, Sanders WG, Cheung AK, Terry C (2010). Correlation of tissue drug concentrations with in vivo magnetic resonance images of polymer drug depot around arteriovenous graft. Journal of controlled release, 146(1), 23-30.
  113. Sanders WG, Hogrebe PC, Grainger DW, Cheung AK, Terry C (2012). A biodegradable perivascular wrap for controlled, local and directed drug delivery. Journal of controlled release, 161, 81-89.
  114. Terry CM, Li L, Li H, Zhuplatov I, Blumenthal DK, Kim S-E, Owen SC, Kholmovski EG, Fowers KD, Rathi R, Cheung A (2012). In vivo evaluation of the delivery and efficacy of a sirolimus-laden polymer gel for inhibition of hyperplasia in a porcine model of arteriovenous hemodialysis graft stenosis. Journal of controlled release, 160, 459-467.
  115. Ramkumar N, Cheung AK, Pappas LM, Roberts WL, Beddhu (2004). Association of obesity with inflammation in chronic kidney disease: a cross-sectional study. Journal of renal nutrition, 14(4), 201-7.
  116. Beddhu S, Cheung AK, Larive B, Greene T, Kaysen GA, Levey AS, Rocco M, Sarnak M, Toto R, Eknoyan (2007). Inflammation and inverse associations of body mass index and serum creatinine with mortality in hemodialysis patients. Journal of renal nutrition, 17(6), 372-80.
  117. Cheung AK, Terry C, Li (2008). Pathogenesis and local drug delivery for prevention of vascular access stenosis. Journal of renal nutrition, 18(1), 140-5.
  118. Sanders WG, Morisseau C, Hammock BD, Cheung AK, Terry C (2012). Soluble epoxide hydrolase expression in a porcine model of arteriovenous graft stenosis and anti-Inflammatory effects of a soluble epoxide hydrolase inhibitor. American journal of physiology. Cell physiology,
  119. Zhou G, Liu X, Cheung AK, Huang (2015). Efficacy of aliskiren, compared with angiotensin II blockade, in slowing the progression of diabetic nephropathy in db/db mice: should the combination therapy be a focus? (PMID: 26175845). American journal of transplantation, (15), 825-840.
  120. Goldfarb-Rumyantzev AS, Chelamcharla M, Bray BE, Leypoldt JK, Lavasani I, Nelson N, Lavasani T, Baird B, Cheung A (2009). Volume indicators and left ventricular mass during aggressive volume management in patients on thrice-weekly hemodialysis. Nephron. Clinical practice, 113(4), c270-80.
  121. Zhuplatov SB, Masaki T, Blumenthal DK, Cheung A (2006). Mechanism of dipyridamole's action in inhibition of venous and arterial smooth muscle cell proliferation. Basic & clinical pharmacology & toxicology, 99(6), 431-9.
  122. Brinton MR, Stewart RJ, Cheung AK, Christensen DA, Shiu Y-T (2011). Modelling ultrasound-induced mild hyperthermia of hyperplasia in vascular grafts. Theoretical biology & medical modelling, 8, 42.
  123. Zhu W, Masaki T, Bae YH, Rathi R, Cheung AK, Kern S (2006). Development of a sustained-release system for perivascular delivery of dipyridamole. Journal of biomedical materials research. Part B, Applied biomaterials, 77(1), 135-43.
  124. Ramkumar N, Beddhu S, Eggers P, Pappas LM, Cheung A (2005). Patient preferences for in-center intense hemodialysis. Hemodialysis international. International Symposium on Home Hemodialysis, 9(3), 281-95.
  125. Agar BU, Akonur A, Cheung AK, Leypoldt J (2011). A simple method to estimate phosphorus mobilization in hemodialysis using only predialytic and postdialytic blood samples. Hemodialysis international. International Symposium on Home Hemodialysis, 15, S9-S14.
  126. Ambrosius WT, Sink KM, Foy CG, Berlowitz DR, Cheung AK, Cushman WC, Fine LJ, Goff DC Jr, Johnson KC, Killeen AA, Lewis CE, Oparil S, Reboussin DM, Rocco MV, Snyder JK, Williamson JD, Wright JT Jr, Whelton PK, The SPRINT Study Research Group (2014). The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: The Systolic Blood Pressure Intervention Trial (SPRINT). (PMID: 24902920). Clinical trials (London, England), (11), 532-546.
  127. Allon M, Litovsky SH, Tey JCS, Sundberg CA, Zhang Y, Chen Z, Fang Y, Cheung AK, Shiu Y (2019). Abnormalities of vascular histology and collagen fiber configuration in patients with advanced chronic kidney disease. The journal of vascular access, 20(1), 31-40.
  128. Kwan BC, Beddhu S, Kronenberg F, Cheung A (2006). Does statin therapy improve cardiovascular outcomes in patients with type 2 diabetes receiving hemodialysis?. Nature clinical practice. Nephrology, 2(2), 76-7.
  129. Terry CM, Zhuplatov I, He Y, Wun TC, Kim SE, Cheung AK (2015). Assessment of novel anti-thrombotic fusion proteins for inhibition of stenosis in a porcine model of arteriovenous graft. (PMID: 26360605). PloS one,
  130. Cheung AK, Greene T, Leypoldt JK, Yan G, Allon M, Delmez J, Levey AS, Levin NW, Rocco MV, Schulman G, Eknoyan (2008). Association between serum 2-microglobulin level and infectious mortality in hemodialysis patients. Clinical journal of the American Society of Nephrology, 3(1), 69-77.
  131. Kopple JD, Cheung AK, Christiansen JS, Djurhuus CB, El Nahas M, Feldt-Rasmussen B, Lange M, Mitch WE, Wanner C, Wiedemann J, Ikizler T (2008). OPPORTUNITY: a randomized clinical trial of growth hormone on outcome in hemodialysis patients. Clinical journal of the American Society of Nephrology, 3(6), 1741-51.
  132. Beddhu S, Ma X, Baird B, Cheung AK, Greene (2009). Serum alkaline phosphatase and mortality in African Americans with chronic kidney disease. Clinical journal of the American Society of Nephrology, 4(11), 1805-10.
  133. Filipowicz R, Greene T, Wei G, Cheung AK, Raphael KL, Baird BC, Beddhu (2013). Associations of serum skeletal alkaline phosphatase with elevated C-reactive protein and mortality. Clinical journal of the American Society of Nephrology, 8(1), 26-32.
  134. Agar BU, Akonu RA, Lo Y-C, Cheung AK, Leypoldt J (2011). Kinetic model of phosphorus mobilization during and after short and conventional hemodialysis. Clinical journal of the American Society of Nephrology, 6, 2854-2860.
  135. Shastri S, Tangri N, Tighiouart H, Beck GJ, Vlagopoulos P, Ornt D, Eknoyan G, Kusek JW, Herzog C, Cheung AK, Sarnak M (2012). Risk factors and a prediction model for sudden cardiac in the HEMO Study. Clinical journal of the American Society of Nephrology, 7, 123-130.
  136. Jovanovich A, Chonchol M, Cheung AK, Kaufman JS, Greene T, Roberts WL, Smits G, Kendrick J, and the HOST Investigator (2012). Racial differences in markers of mineral metabolism in advanced chronic kidney disease. Clinical journal of the American Society of Nephrology, 7, 640-647.
  137. Yan G, Cheung AK, Ma JZ, Yu AJ, Greene T, Oliver MN, Yu W, Norris K (2013). The associations between race and geographic area and quality-of-care indicators in patients approaching ESRD. (PMID: 23493380). Clinical journal of the American Society of Nephrology, (8), 610-618.
  138. . Yan G, Norris KC, Yu AJ, Ma JZ, Greene T, Yu W, Cheung AK (2013). The relationship of age, race and ethnicity with survival in dialysis patients. (PMID: 23539227). Clinical journal of the American Society of Nephrology, (8), 953-961.
  139. Yan G, Norris KC, Greene T, Yu AJ, Ma JZ, Yu W, Cheung A (2014). Race/ethnicity, age, and risk of hospital admission and length of stay during the first year of maintenance hemodialysis, (PMID: 24948142). Clinical journal of the American Society of Nephrology, (9), 1402-1409.
  140. Palit S, Chonchol M, Cheung AK, Kaufman J, Smits G, Kendrick (2015). Association of BP with death, cardiovascular events, and progression to chronic dialysis in patients with advanced kidney disease. (PMID: 25979975). Clinical journal of the American Society of Nephrology, (10), 934-940.
  141. Yan G, Cheung AK, Greene T, Yu AJ, Oliver MN, Yu W, Ma JZ, Norris K (2015). Interstate variation in receipt of nephrologist care in US patients approaching ESRD: race, age, and state characteristics. Clin J Am Soc Nephrol 10:1979-1988, 2015 (PMID: 26450930). Clinical journal of the American Society of Nephrology,
  142. Wali RK, Iyengar M, Beck GJ, Chartyan DM, Chonchol M, Lukas MA, Cooper C, Himmelfarb J, Weir MR, Berl T, Henrich WL, Cheung A (2011). Efficacy and safety of carvedilol in treatment of heart failure in chronic kidney disease: A meta-analysis of randomized trials. Circulation. Heart failure, 4, 18-26.
  143. Butler J, Zannad F, Fitchett D, Zinman B, Koitka-Weber A, von Eynatten M, Zwiener I, George J, Brueckmann M, Cheung AK, Wanner (2019). Empagliflozin Improves Kidney Outcomes in Patients With or Without Heart Failure. Circulation. Heart failure, 12(6), e005875.
  144. Zhu W, Masaki T, Cheung AK, Kern S (2009). In-vitro Release of Rapamycin from a Thermosensitive Polymer for the Inhibition of Vascular Smooth Muscle Cell Proliferation. Journal of bioequivalence & bioavailability, 1, 3-12.
  145. Guo X, Zhou G, Guo M, Cheung AK, Huang Y, Beddhu (2014). Adiponectin retards the progression of diabetic nephropathy in db/db mice by counteracting angiotensin II, (PMID: 24744899). Physiological reports, 2e00230.
  146. Leypoldt JK, Cheung A (1999). The effect of low dialysate flow rate on hemodialyzer mass transfer-area coefficients of urea and creatinine. Home hemodialysis international. International Symposium on Daily Home Hemodialysis, 3, 51-54.
  147. Zhang JL, Morrell G, Rusinek H, Warner L, Vivier PH, Cheung AK, Lerman LO, Lee V (2014). Measurement of renal tissue oxygenation with blood oxygen level-dependent MRI and oxygen transit modeling. (PMID: 24452640). (306), F579-587.

Review

  1. Cheung AK (1993). Interactions between plasma proteins and hemodialysis membranes. [Review]. Adv Nephrol Necker Hosp, 22, 417-37.
  2. Levey AS, Inker LA, Matsushita K, Greene T, Willis K, Lewis E, de Zeeuw D, Cheung AK, Coresh J (2014). GFR decline as an end point for clinical trials in CKD: A scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration, 64:821-835 (PMID: 25441437). American journal of kidney diseases,
  3. Leypoldt JK, Cheung A (1996). Characterization of molecular transport in artificial kidneys. Artificial organs, 20(5), 381-9.
  4. Roy-Chaudhury P, Sukhatme VP, Cheung A (2006). Hemodialysis vascular access dysfunction: a cellular and molecular viewpoint. Journal of the American Society of Nephrology, 17(4), 1112-27.
  5. Kwan BC, Kronenberg F, Beddhu S, Cheung A (2007). Lipoprotein metabolism and lipid management in chronic kidney disease. Journal of the American Society of Nephrology, 18(4), 1246-61.
  6. Isakova T, Ix JH, Sprague SM, Raphael KL Fried L, Gassman JJ, Raj D, Cheung AK, Kusek JW, Flessner MF, Wolf M, Block G (2015). Rationale and approaches to phosphate and fibroblast growth factor 23 reduction in CKD (PMID: 25967123). Journal of the American Society of Nephrology, 26, 2328-2339.
  7. Cheung A (1994). Quantitation of dialysis. The importance of membrane and middle molecules. Blood purification, 12(1), 42-53.
  8. Redon J, Martinez F, Cheung A (2010). Special considerations for antihypertensive agents in dialysis patients. Blood purification, 29(2), 93-8.
  9. Cheung A (1992). Clinical phenomena induced by complement and leukocyte interactions with artificial surfaces. Journal of clinical apheresis, 7(3), 147-8.
  10. Li L, Terry CM, Shiu YT, Cheung A (2008). Neointimal hyperplasia associated with synthetic hemodialysis grafts. Kidney international, 74(10), 1247-61.
  11. Zhang JL, Morrell G, Rusinek H, Sigmund EE, Chandarana H, Lerman LO, Prasad PV, Niles D, Artz N, Fain S, Vivier PH, Cheung AK, Lee VS (2014). New magnetic resonance imaging methods in nephrology (PMID: 24067433). Kidney international, 85, 768-778.
  12. Cheung AK, Lemke (1994). Criteria and standardization for biocompatibility. Nephrology, dialysis, transplantation, 9 Suppl 2, 72-6.
  13. Cheung A (1994). Complement activation as index of haemodialysis membrane biocompatibility: the choice of methods and assays. Nephrology, dialysis, transplantation, 9 Suppl 2, 96-103.
  14. Cheung A (1996). Stages of future technological developments in haemodialysis. Nephrology, dialysis, transplantation, 11 Suppl 8, 52-8.
  15. Charney DI, Walton DF, Cheung A (1993). Atherosclerosis in chronic renal failure. Current opinion in nephrology and hypertension, 2(6), 876-82.
  16. Leypoldt JK, Cheung A (1998). Evaluating volume status in hemodialysis patients. Advances in renal replacement therapy, 5(1), 64-74.
  17. Henderson LW, Clark WR, Cheung A (2001). Quantification of middle molecular weight solute removal in dialysis. Seminars in dialysis, 14(4), 294-9.
  18. Nissenson AR, Agarwal R, Allon M, Cheung AK, Clark W, Depner T, Diaz-Buxo JA, Kjellstrand C, Kliger A, Martin KJ, Norris K, Ward R, Wish (2004). Improving outcomes in CKD and ESRD patients: carrying the torch from training to practice. Seminars in dialysis, 17(5), 380-97.
  19. Leypoldt JK, Cheung A (2006). Revisiting the hemodialysis dose. Seminars in dialysis, 19(2), 96-101.
  20. Cheung AK, Leypoldt J (1998). Evaluation of hemodialyzer performance. Seminars in dialysis, 11, 131-137.
  21. Leypoldt JK, Cheung A (1999). Extracellular volume in nocturnal hemodialysis. Seminars in dialysis, 12, S50-S54.
  22. Charney DI, Walton DF, Cheung A (1994). Difficult management problems in dialysis: Impotence II. Seminars in dialysis, 7, 22-29.
  23. Raphael KL, Cheung A (2011). Implications of the Frequent Hemodialysis Network-Daily Trial. Seminars in dialysis, 24, 621-628.
  24. Cheung A (2009). Is lipid control necessary in hemodialysis patients?. Clinical journal of the American Society of Nephrology, 4 Suppl 1, S95-101.
  25. Okusa MD, Molitoris BA, Palevsky PM, Chinchilli VM, Liu KD, Cheung AK, Weisbord SD, Faubel S, Kellum JA, Wald R, Chertow GM, Levin A, Waikar SS, Murray PT, Parikh CR, Shaw AD, Go AS, Chawla LS, Kaufman JS, Devarajan P, Toto RM, Hsu CY, Greene TH, Mehta RL, Stokes JB, Thompson AM, Thompson BT, Westenfelder CS, Tumlin JA, Warnock DG, Shah SV, Xie Y, Duggan EG, Kimmel PL, Star R (2012). Design of clinical trials in acute kidney injury: A report from an NIDDK Workshop ¿ prevention trials. Clinical journal of the American Society of Nephrology, Epub ahead, of print.
  26. Molitoris BA, Okusa MD, Palevsky PM, Chawla LS, Kaufman JS, Devarajan P, Toto RM, Hsu CY, Greene TH, Faubel SG, Kellum JA, Wald R, Chertow GM, Levin A, Waikar SS, Murray PT, Parikh CR, Shaw AD, Go AS, Chinchilli VM, Liu KD, Cheung AK, Weisbord SD, Mehta RL, Stokes JB, Thompson AM, Thompson BT, Westenfelder CS, Tumlin JA, Warnock DG, Shah SV, Xie Y, Duggan EG, Kimmel PL, Star R (2012). Design of clinical trials in AKI: A Report from an NIDDK Workshop. Trials of patients with sepsis and in selected hospital settings. Clinical journal of the American Society of Nephrology, Epub ahead, of print.
  27. Palevsky PM, Molitoris BA, Okusa MD, Levin A, Waikar SS, Wald R, Chertow GM, Murray PT, Parikh CR, Shaw AD, Go AS, Faubel SG, Kellum JA, Chinchilli VM, Liu KD, Cheung AK, Weisbord SD, Chawla LS, Kaufman JS, Devarajan P, Toto RM, Hsu CY, Greene T, Mehta RL, Stokes JB, Thompson AM, Thompson BT, Westenfelder CS, Tumlin JA, Warnock DG, Shah SV, Xie Y, Duggan EG, Kimmel PL, Star R (2012). Design of clinical trials in acute kidney injury: Report from an NIDDK Workshop on trial methodology. Clinical journal of the American Society of Nephrology, Epub ahead, of print.
  28. Molitoris BA, Okusa MD, Palevsky PM, Chawla LS, Kaufman JS, Devarajan P, Toto RM, Hsu CY, Greene TH, Faubel SG, Kellum JA, Wald R, Chertow GM, Levin A, Waikar SS, Murray PT, Parikh CR, Shaw AD, Go AS, Chinchilli VM, Liu KD, Cheung AK, Weisbord SD, Mehta RL, Stokes JB, Thompson AM, Thompson BT, Westenfelder CS, Tumlin JA, Warnock DG, Shah SV, Xie Y, Duggan EG, Kimmel PL, Star RA (2012). Design of clinical trials in AKI: A Report from an NIDDK Workshop. Trials of patients with sepsis and in selected hospital settings (PMID: 22442184). Clinical journal of the American Society of Nephrology, 7, 856-860.
  29. Palevsky PM, Molitoris BA, Okusa MD, Levin A, Waikar SS, Wald R, Chertow GM, Murray PT, Parikh CR, Shaw AD, Go AS, Faubel SG, Kellum JA, Chinchilli VM, Liu KD, Cheung AK, Weisbord SD, Chawla LS, Kaufman JS, Devarajan P, Toto RM, Hsu CY, Greene T, Mehta RL, Stokes JB, Thompson AM, Thompson BT, Westenfelder CS, Tumlin JA, Warnock DG, Shah SV, Xie Y, Duggan EG, Kimmel PL, Star RA (2012). Design of clinical trials in acute kidney injury: Report from an NIDDK Workshop on trial methodology. 7:844-850, (PMID: 22442182). Clinical journal of the American Society of Nephrology,
  30. Cheung A (2009). Contributing author on several topics.

Book Chapter

  1. Cheung A (1998). Hemodialysis and hemofiltration. 408-415.
  2. Leypoldt JK, Cheung A (1998). Dialyzer reprocessing and solute clearances. 3, 333-339.
  3. Pereira BG, Cheung A (2000). Biocompatibility of hemodialysis membrane. 32-56.
  4. Ambalavanan S, Rabetoy G, Cheung (1999). High efficiency and high flux hemodialysis. 3, 1-3.10.
  5. Pereira BJG, Cheung A (2000). Complications of biocompatibility of hemodialysis membranes. 41-68.
  6. Cheung A (2001). Hemodialysis and hemofiltration. In: National Kidney Foundation Primer on Kidney Diseases. 396-404.
  7. Cheung A (1993). Dialyzer biocompatibility: Practical considerations. 75-77.
  8. Cheung A (1994). Hemodialysis and hemofiltration. 258-265.
  9. Walton DF, Cheung A (1995). Membrane biocompatibility.
  10. Walton DF, Cheung A (1997). Membrane biocompatibility. 1029-1042.
  11. Cheung AK, Mohammad SF, Leypoldt J (1997). Adhesion molecules and artificial membranes. 643-678.
  12. Greene T, Cheung AK, Krediet (2001). : The design of randomized clinical trials in dialysis patients. 1521-1542.
  13. Cheung A (2005). Hemodialysis and hemofiltration. 464-476.
  14. Wali R, Kaluvapalle JR, Cheung A (2008). Complications associated with hemodialysis. 891-912.
  15. Ford L, Ward RA, Cheung A (2009). Choice of the hemodialysis membrane. 1-11.
  16. Reddy B, Cheung AK (2009). Hemodialysis. 201-223.
  17. Leypoldt JK, Culleton BF, Cheung A (2010). Hemodialysis adequacy. 320-334.
  18. Leypoldt JK, Cheung AK: Fluid removal during hemodialysi (1999). Fluid removal during hemodialysis. 1-23.
  19. Cheung, A (2009). Hemodialysis and hemofiltration. 446-458.
  20. Leypoldt JK, Henderson LW, Cheung A (2012). Middle molecules.

Case Report

  1. Loghman-Adham M, Walton D, Iverius PH, Deiss A, Knight JA, Cheung A (1997). Spurious hypophosphatemia in a patient with multiple myeloma. American journal of kidney diseases, 30(4), 571-5.
  2. Beckwith C, Flaharty KK, Cheung AK, Beatty P (1993). Fanconi's syndrome due to ifosfamide. Bone marrow transplantation, 11(1), 71-3.

Editorial

  1. Chang TI, Cheung AK, Chertow G (2010). Blood pressure control in type 2 diabetes mellitus. American journal of kidney diseases, 56(6), 1029-31.
  2. Cheung AK, Greene (2009). Effect of membrane permeability on survival of hemodialysis patients. Journal of the American Society of Nephrology, 20(3), 462-4.
  3. Henderson LW, Leypoldt JK, Lysaght MJ, Cheung A (1997). Death on dialysis and the time/flux trade-off. Blood purification, 15(1), 1-14.
  4. Cheung A (1994). Biocompatibility of Dialysis membrane: Practical considerations. 139-149.

Other

  1. Levin NW, Kotanko P, Eckardt KU, Kasiske BL, Chazot C, Cheung AK, Redon J, Wheeler DC, Zoccali C, London G (2010). Blood pressure in chronic kidney disease stage 5D-report from a Kidney Disease: Improving Global Outcomes controversies conference. Kidney international, 77(4), 273-84.
  2. Cheung AK, Ward R (2011). ASN Renal Weekends slide set, American Society of Nephrology.